AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2025
Aug 13, 2025
32180_dirs_2025-08-12_7aaf2282-c46a-47cd-b2d3-8e779435a045.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2025-08-11
Reporting Person: Landry Robert E (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-11 | Stock Option (Right to Buy) | $12.44 | A | 62000 | Acquired | 2035-08-10 | Common Stock (62000) | Direct |
Footnotes
F1: Stock options vest in 36 equal monthly installments starting one month after grant date of August 11, 2025.